CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis
Young Mo Kang, Young-Eun Park, Won Park, Jung-Yoon Choe, Chul-Soo Cho, Seung-Cheol Shim, Sang Cheol Bae, Chang-Hee Suh, Hoon-Suk Cha, Eun Mi Koh, Yeong-Wook Song, Bin Yoo, Shin-Seok Lee, Min-Chan Park, Sang-Heon Lee, Catherine Arendt, Willem Koetse, Soo-Kon Lee
    DOI: https://doi.org/10.3904/kjim.2016.213

Excel Download

Janus-Kinase-Inhibitor Baricitinib bei rheumatoider Arthritis
rheuma plus. 2018;   Crossref logo
Link1 Link2 Link3

American College of Rheumatology hybrid analysis of certolizumab pegol plus methotrexate in patients with active rheumatoid arthritis: Data from a 52-week phase III trial
Arthritis Care & Research. 2010;63(1):128-134   Crossref logo
Link1

EFFICACY OF BROMOCRIPTINE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS RECEIVING METHOTREXATE THERAPY
European Journal of Internal Medicine. 2011;22:S85   Crossref logo
Link1 Link2

Janus-Kinase-Inhibitor Baricitinib bei rheumatoider Arthritis
Der Internist. 2017;58(12):1341-1344   Crossref logo
Link1 Link2 Link3

Efficacy and safety of methotrexate plus certolizumab pegol or placebo in active rheumatoid arthritis
Zeitschrift für Rheumatologie. 2016;76(6):528-534   Crossref logo
Link1 Link2 Link3 Link4

Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
Arthritis & Rheumatology. 2016;68(11):2584-2592   Crossref logo
Link1 Link2 Link3

Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
Arthritis & Rheumatism. 2008;58(11):3319-3329   Crossref logo
Link1

Efficacy and Safety of ABT-494, a Selective JAK-1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Arthritis & Rheumatology. 2016;68(12):2857-2866   Crossref logo
Link1 Link2 Link3

Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone
Arthritis & Rheumatism. 2010;62(1):33-43   Crossref logo
Link1

Metabolic Profiling Predicts Response to Anti-Tumor Necrosis Factor α Therapy in Patients With Rheumatoid Arthritis
Arthritis & Rheumatism. 2013;65(6):1448-1456   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.